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INTRODUCTION 
Protozoan parasites of man constitute membership in all 
major groups of this phylum (Jawetz, et al, 1976; Burrows, 
1973) . The flagellated Trypanosome, a member of the group 
Mastigophora is a serious health problem in tropical climates, 
where the organism is the etiological agent of sleeping sick­
ness and Chagas' disease. Members of the group Sarcodina 
are generally ameboid, and include the intestinal pathogen 
Entamoeba, and Nagleria, which causes a serious encephalitis. 
Malaria, along with Toxoplasmosis, is one of the few 
Sporozoan diseases of man. Sporozoan are characterized 
by having a complete life cycle, often in two hosts. Dis­
tribution of the disease is confined primarily to the tropi-
cal and subtropical zones of the world. It is no longer a 
major health problem in areas of temperate climate. Malaria 
remains, however, the most common serious infectious dis-
ease in man, worldwide (Benenson, 1975) . In the United 
States, a relatively large increase in the number of re­
ported cases of malaria occurred during the late 1960's and 
early 1970's, as military personnel returned from Vietnam 
(CDC Annual Summary, 1978) . 
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Malaria is caused by members of the genus Plasmodium. 
Four species of Plasmodium are the etiological agents of 
malaria in man; f. ovale, f. malariae, f. vivax, and f. 
falciparum, the last being the most serious and fatal (Mar­
kell and Voge, 1976) .  
The disease in man is primarily an infection of erythro­
cytes in the circulatory system. Malaria is transmitted to 
man almost exclusively by the feedings of female Anopheles 
mosquitoes. Clinical signs, including malaise, headache, 
fever and chills occur in a cyclic pattern, corresponding 
to the periodic release of new parasites from the infected 
erythrocytes. The timing of the fever and chill cycles will 
vary with the species of Plasmodium causing the disease. 
Complications such as blackwater fever, in which the host 
immune system attacks and lyses its' own infected and non­
infected erythrocytes may occur, especially with infections 
by f. faciparum (Beneson, 1975; Markell and Voge, 1976). 
Relapses do occur with f. ovale, f. malariae and P. 
vivax, but not with f. falciparum. To be completely effec­
tive, a treatment must eliminate all parasites in the 
circulatory system and solid tissue phases of a natural 
infection. Latent infections may persist for thirty years 
or more (Burrows, 197 3) . 
Quinine, and its synthetic derivative, chloroquine, 
have been the traditional drugs of choice in the treatment 
of prophylaxis of malaria. Both suppress nucleic acid 
metabolism in schizonts (parasites of the erythrocytic 
3 
cycle) . Neither drug, however, has proven to be ideal be­
cause of the existance of Plasmodium strains resistant 
to these and other drugs. Following the first world war, 
a large number of synthetic antimalarial agents were de­
veloped (Thompson, 1972) . With the use of antimalarial drugs 
came the development of Plasmodium strains resistant to the 
effects of one or more such drugs. Most recently, attention 
has been focused on chloroquine and multiple drug resistant 
strains of P. falciparum in South East Asia (Kinnamon and 
Roth, 1975) . The appearance of such drug resistant strains 
has spurred the U. S. Army and private industry to search for 
new antimalarial agents and treatment regimens. 
Since there has been little success in culturing Plas­
modium in vitro (Peters and Howells, 1978) ,  the traditional 
method of testing potential antimalarial agents has been 
in experimental animal systems infected with their own 
species of Plasmodium. One such model is the mouse-P. 
berghei system. 
P. berghei is one of twelve rodent host-specific species 
of Plasmodium native to Central Africa (Killick-Kendrick, 
1978) . The protozoan is a natural parasite of the tree 
rat, Thamnomys surdaster (Vincke, 1954; cited by Landau and 
Boulard, 1978) .  
The parasite maintains a two host life cycle in natural 
infections, one vertebrate host, the other invertebrate. 
Gametocytes are ingested by the female Anopheles mosquito 
during a blood feeding on the vertebrate host. The macro-
4 
gametocytes become female macrogametes in the lumen of 
the mosquito midgut. The microgametocytes undergo ex­
flagellation to become male microgametes. The macrogamete 
is then fertilized by the microgamete to form a motile 
ookinete, which in turn migrates into the wall of the midgut. 
Here the ookinetes mature into oocysts within seven to fif­
teen days, depending on the ambient temperature. Upon 
maturation, the oocysts rupture and liberate sporozoites 
which migrate from the midgut wall to the salivary glands. 
This is the sporogenic, or sexual cycle. 
With subsequent feeding by the mosquito, sporozoites 
are transferred from the mosquitoes' salivary glands to the 
blood stream of the vertebrate host. From here, sporozoites 
invade the liver and enter the hepatocytes (this portion of 
the vertebrate infection process is absent in animals inocu­
lated with blood containing only erythrocytic stages) . While 
in the hepatocytes, the sporozoites give rise to pre-erythro­
cytic schizonts. This is the primary tissue phase of in­
fections. The schizonts mature in the hepatocytes and 
eventually rupture them, releasing merozoites into the 
circulatory system. In E· berghei infections, this initial 
release of merozoites occurs within forty-eight to seventy­
two hours of inoculation with sporozoites. Once in the 
circulatory system, the merozoites enter erythrocytes, where 
they subsequently divide and form trophozoites or ring 
stages (Figures 1 and 2) , schizonts (Figure 3), and finally 
new merozoites. 
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Figure 1 
Geimsa's stain of early trophozoite (ring) stage 
in mouse erythrocytes, magnified lOOOX. Early 
trophozoite (ring) stages in mouse erythrocytes 
stained with Geimsa's solution, magnified lOOOX. 
Figure 2 
Late trophozoite stages in mouse erythrocytes 
stained with Geimsa's solution, magnified lOOOX. 
Figure 1 
Figure 2 
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These merozoites then rupture the swollen remains of 
the erythrocyte and re-enter the circulatory system to in­
fest other erythrocytes. Some merozoites change into gameto­
cytes while in the erythrocyte. Hepatocytes are not in­
fected by the circulating merozoites. This is the schizogenic 
or asexual cycle (Flynn, 1973; Killick-Kendrick, 1978) . The 
ruptured erythrocytes release toxic waste products, accrued 
during schizogeny, which cause the fever and chills associated 
with malaria (Markell and Voge, 1976) . 
The various subspecies and strains of E· berghei exhibit 
certain characteristics which distinguish them from other 
non-murine Plasmodium species. The merozoites show a defi­
nite prediliction for reticulocytes over mature erythrocytes 
(Figure 4) . The primary tissue phase, when it occurs is 
relatively short, under fifty hours (Killick-Kendrick, 1974). 
Sporogeny is rapid, taking only nine days to complete. Rats, 
hamsters and mice are naturally receptive to infection by 
inoculation of the erythrocytic stages (Landau and Boulard, 
1978) . 
The number of parasites detectable in the blood stream 
rises rapidly, with no decreases in parasitemia. When un­
checked, the infection generally results in the death of the 
animal in seven to fourteen days (Voelii, 1965; Sengers et al., 
1971) . Increases in SGP-T and SGO-T transaminases have 
been detected in the blood of infected mice, along with a 
concomitant drop in fasting glucose levels in heavily in­
fected mice (Sadun, et al., 1965) . The latter effect is 
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Figure 3 
Polymorphonucleocytes and early trophozoite 
stages within infected mouse erythrocytes 
stained with Geimsa's solution, magnified 
lOOOX. 
Figure 4 
Erythrocytes and reticulocytes (purple) in the 
blood of normal mice stained with Geimsa's solu­
tion, magnified lOOOX. 
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probably due to an increased demand for glucose by Plasmoidia 
infected erythrocytes (Bryant et al., 1965) . 
Most drugs active against human malaria exhibit similar 
effectiveness against E· berghei (Thompson, 1972) . With the 
development of multidrug resistant strains of E- berghei, it 
has been possible to develop massive drug testing programs 
utilizing animals relatively inexpensive and easy to manipu­
late (Peters and Howells, 1978) . 
Statement of Purpose 
The objective of this study was to determine whether 
or not salinomycin, a drug with proven effectiveness against 
intestinal sporozoan parasites, has any effect on the sur­
vival time of mice infected with P. berghei. 
Salinomycin is a monocarboxylic acid polyether anti­
biotic with a tricyclic spiroketal ring system and an unsatu­
rated six-membered ring (Kinashi et al., 1973) . It is 
a natural fermentation product of Streptomyces albus 
(Miyazaki et al., 1974) . The drug is highly insoluble in 
distilled water and highly soluble in such organic com­
pounds as methanol, acetone and ethyl ether at room temper­
ature. Such selective solubility thus presents potential 
problems with dispersal in suitable solvents for in vivo 
experimental systems. Activity against Bacillus test 
organisms remains high at neutral to basic pH, while de­
creasing steadily as the pH of the diluent solution lowered 
below six. Salinomycin activity remained stable at a variety 
11 
of ambient temperatures, from 5 to 6o
0
c.
1 
Salinomycin is a cationic ionophore (Mitani et al. , 
1975) . The drug has the ability to complex with and cause 
the migration of select monovalent cationic alkalai 
metals, such as sodium, potassium, and cesium across phos­
pholipid bilayer membranes. Experiments performed with rat 
mitochondria indicate that salinomycin causes the rapid 
release of potassium from the mitochondrial membranes, 
shutting down both coupled and uncoupled respiration within 
these membranes (Mituaki et al., 1976). 
This selective transport activity of salinomycin seems 
to be deleterious to the growth of certain gram positive 
bacteria, mycobacteria and fillamentous fungi (Myazaki et 
al. , 1974). Danforth et al., (1977) demonstrated the orally 
administered salinomycin is effective in eliminating the 
coccidial intestinal sporozoan Emeria from the digestive 
tracts of battery raised broiler chickens. Salinomycin 
has also been shown to eliminate coccidia from the intes­
tines of cattle (Bens and Ernst, 1979) . 
The anticoccidial activity of salinomycin appears to 
be both coccidiocidal and coccidiostatic (Chappel, 1979) . 
Drug activity is primarily directed against nuclear repli­
cation during the transition from sporozoite to trophozoite 
stage in the intestinal endothelium. Salinomycin when ad­
ministered through the entire life cycle of coccidia in 
Kaken Chemical Company, Salinomycin Data Sheet, 1974. 
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experimental chickens shuts down activity of all asexual 
stages. 
The effects of salinomycin on normal hematologic 
parameters were first determined. Next, attempts were made to 
determine the optimal intraperitoneal (I.P.) dose and in­
jection frequency for treatment of P. berghei in mice. The 
size of the initial inocula and parasitemia levels when 
treatment was begun were varied in order to determine the 
optimal time during the erythrocytic cycles to begin I.P. 
administration of salinomycin. Finally, the effects of 
orally administered salinomycin on P. berghei induced murine 
malaria were examined. 
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MATERIALS AND METHODS 
Animals 
20-25 gram male ICR mice were obtained from Flow Re­
search Animals, Inc. , Dublin, VA, and were maintained on 
Respond 3000 Rodent Chow and tap water ad libitum. Mice 
were generally allowed to increase their body weight to 
25-39 grams before being used in experiments. All mice in 
experiments involving infectious materials were housed in 
special isolated workrooms. Mice were kept ten to a cage, 
unless otherwise indicated. Cage bedding was Beta-chip 
hardwood. 
Plasmodium 
The lethal NYU-2 strain of Plasmodium berghei was used 
in all experiments. The parasite was supplied by Dr. David 
John of the Department of Microbiology, Medical College of 
Virginia. 
Plasmodium stocks were maintained in vivo by injecting 
I. P. male ICR mice with infected blood diluted in a 0.1 M 
solution of sodium citrate. The infected blood was obtained 
from previously injected mice by incisions in tail tips with 
straight razors. Plasmodium was passaged every seven or 
eight days. Two or three drops of blood from infected ani­
mals were diluted in 1 ml of sodium citrate solution, and 
0.2 cc injected I.P. into each mouse. Injected mice lived 
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an average of 14 days and had parasitemias detectable by 
Geimsa' s Stain within two days. 
Innocula for experiments were prepared by obtaining 
the percent parasitemia and performing total erythrocyte 
counts with a hemacytometer (see below) for an infected donor 
animal. The number of infected erythrocytes per unit volume 
of whole blood were calculated. An appropriate volume of 
blood was then removed via cardiac puncture and diluted in 
sodium citrate solution to an appropriate concentration for 
subsequent injection into test mice. 
Salinomycin (Figure 5) was obtained from Dr. Robert 
Tankersley, Chief Microbiologist, Research Department of 
A. H. Robins, Inc. , in sodium salt form. Stock solutions 
of Salinomycin were made by suspending 100 mg of salinomy­
cin in a solution of 2% absolute ethanol, 40% propylene 
glycol and 58% .16M phosphate buffered saline (PBS) . Final 
concentrations of the stock solution was 2 mg/ml. 
Total Erythrocyte Counts 
Total erythrocyte counts were performed by 2 methods: 
�) Hemacytometer counts. Mouse blood was collected from 
tail tips into 20 µl unopettes, which diluted the blood 
1:100, 000 in saline solution. Two Hemacytometer chambers 
(Clay-Adams) were then charged with diluted blood from the 
unopette. The total number of erythrocytes in the 4 cor­
ner squares and the center square of each chamber at l00X 
magnification were counted and averaged. The following 
15 
Figure 5 
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formula was used to determine the number of cells per mm3 
Erythrocytes counted X Dilution X 4000 
Number of Squares Counted 
2) Electronic Cell Sorter Counts. Mouse blood was ob­
tained as described above in 20 µl amounts. The blood was 
immediately dispersed in enough Isoton solution (Fisher 
Scientific Products) to yield a dilution of 1:100, 000. 
Total erythrocyte counts were performed on a Coulter Counter 
(Coulter Electronics, Hialeah, FL) by sampling each specimen 
of diluted mouse blood twice, correcting each value for 
over-counts and averaging these two figures. 
Hematocrits 
The hematocrit or packed cell volume (PCV) was deter­
mined by filling 75 mm heparinized capillary tubes with 
mouse blood obtained as described previously. The tubes 
were then centrifuged for 8 minutes at 14, 500 RPM in an 
International Microcapillary Centrifuge (International 
Equipment, Needham Heights, MA). Packed cell volume is 
defined as that percentage of the total blood volume con­
sisting of blood cells. 
Hemoglobin 
Hemoglobin levels in the blood were determined by 
collecting 10 µl of mouse blood in 6 ml of cyanometh-
hemaglobin reagent (Stambio Products, San Antonio, TX) , 
shaking, then reading absorbance at 540 nm within 45 min­
utes of dilution. Readings were made on a Coleman Junior 
II Spectrophotometer (Perkins Elmer, Oak Grove, IL) . 
Absorbance was converted to mg hemoglobin/dl blood 
by comparison to a previously established hemoglobin 
standard curve. 
Post-Mortem Examination 
18 
Post mortem examinations were performed periodically 
to confirm deaths due to malaria, and to determine the 
effects of orally administered salinomycin. Moribund mice 
not already dead were sacrificed by cervical dislocations. 
The abdominal cavities of these animals were opened with 
scissors and forceps. When necessary, the liver and spleen 
were examined for darkening and enlargement. In oral admini-
stration experiments, the entire intestinal tract was re­
moved and sectioned. Swabs from the intestinal lining of 
the jejunum and transverse colon were streaked on microscope 
slides with sterile phosphate buffered saline (PBS) and 
examined at l00X while still wet for the presence of Tricho­
monas, adult pinworms and bacteria. Contents from infected 
and treated animals were compared to samples from healthy, 
untreated mice. 
Mean Survival Time (MST) 
The MST value was calculated by multiplying the number 
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of mouse deaths in a group on a particular day by the number 
of days after infection the death occurred. These products 
were them summed and divided by the number of animals counted 
in a particular group. Deaths due to drug toxicity were ex­
cluded. 
Wintrobe Erythrocytic Indexes 
These were determined in order to provide objective 
quantitative standards for the hematologic values determined 
in the experiments described. These values are used to 
define anemias which may be discovered (Davidson and Henry, 
1974) . Values for the percentage of mouse erythrocytes 
fected by one or more malarial parasites were determined by 
direct microscopic examination of stained blood smears. One 
to two drops of mouse blood from tail snips were smeared on 
microscope slides, air dryed and fixed in absolute methanol. 
The slides were then stained for five minutes in a 1: 50 
solution of Geimsa's stain. Smears were then examined at 
lOOOX under an oil immersion objective. At least four fields 
and a minimum of 200 erythrocytes were counted. Percent 
parasitemia was deferred as that percentage of the total 
number of erythrocytes counted that contained Plasmodium. 
Mean Corpuscular Volume (MCV) 
This is the average volume of the erythrocytes of an 
organism. The index is expressed in fl (1 µl = 10
9 
fl) and 
is calculated by the formula: 
Hematocrit Percentage (fl) X 10 
Erythrocyte Count 
20 
Mean Corpuscular Hemoglobin (MCH) 
The weight of the hemoglobin (in picograms) in the 
average erythrocyte in a population of cells. It is de­
termined by the formula: 
Weight of Hemoglobin (pg) in 1 dl of Blood 
Volume of the Blood Sample (dl) X Erythrocyte Count (dl) 
Mean Corpuscular Hemoglobin Concentration (MCHC) 
The MCHC (the ratio of the weight of hemoglobin to the 
average volume of the erythrocyte expressed in g/dl.) was 
calculated by the formula: 
Hemog.lobin (g/dl) X 100 
PCV (ml/100 ml) 
Photomicrographs were taken by the author with a Zeiss 
Photomicroscope #3. Statistical analysis was by Student's 
T-Test. 
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RESULTS 
Lethal Dose Range Determination for J.P. Administered Salino­
mycin in Mice 
In preliminary experiments, seven groups of ten male 
ICR mice (average weight 23 grams) were used to determine 
lethal dose range for salinomycin suspended in ethanol­
propylene glycol-PBS. Ten mice per group received one J.P. 
injection of salinomycin in 0.3 cc ethanol propylene glycol­
PBS diluent. Each group was injected once with 1, 3, 6, 9, 
12, or 15 mg/kg of salinomycin. The eleventh group was 
injected only with diluent. Mice were observed for fourteen 
days after injection for any signs of toxicity or death. As 
shown in Table 1, deaths occurred in groups of mice receiving 
9 or more mg/kg of salinomycin. Signs of toxicity included 
hind leg paralysis, head roration, panting and a hyperactive 
startle reflex. Mice died within three hours of drugs 
administration. No gross pathological changes were noted. 
Effects of an Untreated Infection of P. berghei on Selected 
Hematologic Values of Mice 
Five mice were each infected J.P. with approximately 4 
x 103 Plasmodium bearing erythrocytes in 0.2 cc sodium 
citrate colution. Blood samples from tail snips were taken 
just prior to, and every twenty-four hours after inoculation, 
for twelve days. The hemoglobin, hematocrit and parasitemia 
levels were determined in order to ascertain the effects of 
22 
TABLE 1 
LETHAL DOSE RANGE DETERMINATION FOR I.P. 
ADMINISTERED SALINOMYCIN IN MICE 
Dose Number Deaths/Number Tested % Killed 
Diluent 0/10 0 
1 mg/kg 0/10 0 
3 mg/kg 0/10 0 
6 mg/kg 0/10 0 
9 mg/kg 3/10 30 
12 mg/kg 5/10 50 
15 mg/kg 10/10 100 
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Plasmodium infection. As shown in Table 2, there was a 
slight overall decrease in the hemoglobin and hematocrit lev­
els between day O and day 4. After day 4 the levels of 
these two parameters dropped sharply, while the parasitemia 
levels rose between days 4 and 8, peaking on day 8 (Figure 
6) . Between days 8 and 12, the day the last surviving mice 
died, the parasitemia level dropped somewhat, while the 
hematocrit and hemoglobin concentration leveled off. MST 
was 12.6 days. 
Effects of Salinomycin on Certain Hematologic Values in Mice 
The effects of I. P. injected salinomycin in mice were 
examined in two experiments. In the first experiment, two 
groups of ten mice each with an average weight of 33 grams 
were used. One group was injected with 4 mg/kg/day of 
salinomycin in 0.3 cc diluent three times. The other group 
was similarly injected, but only with diluent. Mouse blood 
was drawn from tail snips and samples were analyzed for 
hematocrit (HCRIT) and hemoblogin (HGB) levels just prior 
to the first injection, twenty-four hours after the last 
injection and five days after the last injection. As illu­
strated in Table 3 mean hemoglobin values for diluent con­
trols and salinomycin administered animals did not vary sig­
nificantly from each other during the course of treatment or 
up to five days afterward. The same lack of variance holds 
true for hematocrit levels of diluent controls and salino­
mycin groups, during treatment and afterwards. 
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TABLE 2 
EFFECTS OF UNTREATED INFECTION OF P. BERGHEI 1ON 
SELECTED HEMATOLOGIC PARAMETERS OF MICE 
Mouse HB (g/dl) HCRIT % 
No. {% PCV} Parasitemia 
1 14.8 46 0 
2 17.6 58 0 
Pre-Injection 3 15.6 48 0 
4 15.6 54 0 
5 13.6 48 0 
Mean 15.4 51 0 
1 12.0 41 0 
2 Days Post-In- 2 14.4 51 0 
fection 3 14.0 58 0 
4 14.4 49 0 
5 12.8 46 0 
Mean 13 .5 47 0 
1 14.4 45 9 
4 Days Post-In- 2 16.0 49 5 
fection 3 16.8 52 8 
4 15.4 48 4 
5 13.6 5 3 9 
Mean 15.2 49 8 
1 9.6 3 3  40 
6 Days Post-In- 2 12. 8 42 24 
fection 3 8.6 35 49 
4 13 .2 43 19 
5 9.2 32 38 
Mean 10.7 32 34 
1 3.8 15 76 
8 Days Post-In- 2 6.2 23 59 
fection 3 3.7 12 73 
4 7.2 27 46 
5 4. 8 17 34 
Mean 5.1 19 58 
1 
10 Days Post-In- 2 2.4 58 
fection 32 
42 
5 2.8 43 
Mean 2.6 49 
12 Days Post In- 2 2.0 11 37 
fection 5 6.6 14 45 
Mean 4.3 13 41 
1In itial in noculum of 4 X 10
3 
infected erythrocytes/mouse in 
0.2 cc sodium citrate solution 
2Mouse died. 
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Figure 6 
Selected Mean Hematologic Parameters of Mice 
during the course of an infection by 
Plasmodium berghei. 
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TABLE 3 
1 
EFFECTS OF I. P. ADMINIS TERED S ALINOM YCIN ON SELECTED HEMATOLOGIC P AR AMETERS OF MICE 
JUST PRIOR FIRST INJECTIOO 24 HOURS AFTER LAS!' INJECTIOO 
HGB (g/ml) HCRIT (% PCV) HGB (g/ml) HCRIT (% PCV) 
Diluent Salino- Diluent Salino- Diluent Salino- Diluent Salino-
Mouse Control mycin Control mycin Control mycin Control mycin 
No. Group Group Group Group 
1 12. 8 12.4 53 50 15. 2 12.8 54 50 
2 14.0 13.0 54 51 14. 0 13.2 54 50 
3 11. 6 12. 8 45 52 14. 4 ---- 1 50 --
4 13. 2 13. 2 49 48 13. 0 14,4 50 50 
5 16.6 14.0 60 55 14.0 13.6 52 50 
6 15.2 12.2 43 44 13. 6 11. 2 47 45 
7 13. 8 13. 6 52 55 12. 4 14. 0 46 51 
8 12.8 13.2 56 54 12.0 14.4 42 52 
9 13.2 12. 8 49 50 11. 2 ---- 1 42 -- 1 
10 9. 6 10. 8 44 49 12. 0 13. 2 46 51 
MEAN 13.3 12. 8 50. 5 50. 8 13. 2 13. 4 48.3 49.9 
1 
4 mg/kg/day in 0.3 cc diluent 3 times, every 24 hours. 
2 
5 DAYS AFTER LAS!' INJECTIOO 
HGB (g/ml) HCRIT (% PCV) 
Diluent Salino- Diluent Salino-
Control mycin Control mycin 
Group Group 
16. 8 11. 6 59 46 
16.0 14.4 55 40 
3 2 2 ---- ---- -- --
----3 15. 6 -- 55 
----3 15.2 -- 60 
----3 13.8 -- 52 
12. 8 16. 0 47 52 
14. 8 15.6 51 56 
12. 4 ----2 47 --2 
13.6 14. 4 53 53 
14. 4 14.6 52 53 
Animal died immediately after injection of salinomycin. Data not collected. 
3 
Mice in diluent control group accidently drowned after 4 days after last injection. 
t-J 
-..i 
In the second experiment, mice were examined just prior 
to the first injection of salinomycin and twenty-four hours 
after the last injection, but not five days after the last 
injection. Erythrocyte counts, done with an electronic cell 
counter, were performed along with hematocrit and hemoglobin 
determinations so that Wintrobe Erythrocytic indexes could 
also be determined (Table 4). Mice in two groups of ten 
animals each (average weight 2 4  grams) were injected with 4 
mg/kg/day of salinomycin or diluent, as previously described. 
The results (Table 4, Figure 7) indicate little or no change 
in any hematologic values after treatment with salinomycin 
or diluent. 
Efficacy of Salinomycin Suspension on the MST of P. berghei 
Infected Mice 
An attempt was made to determine what effect salinomy­
cin might have on the course of malaria infection in mice. 
Two groups of 2 7  gram mice was each injected I.P. with 
5 x 106 Plasmodium infected erythrocytes in 0.3 cc of sodium 
citrate diluent. One group of ten mice received no further 
treatment. The other group, containing twenty mice, re­
ceived 3 subsequent I.P. injections of 8 mg/kg/day of 
salinomycin in 0.3 cc of ethanol-PBS-propylene glycol diluent, 
2 4, 48 and 96 hours after infection. The second group con­
tained 2 0  mice so that any possible deaths due to high 
drug toxicity would not reduce the number of animals in the 
group to statistically unmanageable numbers. As shown in 
2 8  
TABLE 4 
EFFECTS OF I. P. ADMINISTERED SALINOMYCIN
1 
ON SELECTED HEMATOLOGIC VALUES AND 
WINTROBE ERYTHROCYTIC INDEXES OF MICE 
JUST PRIOR TO FIRST INJECTION 
HGB (g/dl ) HCRIT (% PCV) 
Diluent Saline- Diluent Salino-
ERYTHROC'Y'fi 
CDUNT 
24 HRS. AFTER LAST INJECTION 
ERY'IHROCYTE 2 
CDUNT HGB (g/dl ) HCRIT (% PCV) 
Diluent Salino- Diluent Salino- Diluent Saline- Diluent Salino-
Mouse Control mycin Control mycin Control mycin Control mycin Control mycin Cbntrol mycin 
No. Group Group Group Group Group Group 
1 ---- 12. 6 56 51 ---- 14. 0 16. 0  ---- 2 56 -- 10. 5 
2 14. 8 14. 0 58 55 13. 5 16. 4 14. 0 15. 6 53 57 11. 7 14. 7 
3 14. 4 15. 2 54 54 16. 0 14. 0 13. 4 14. 8 53 56 11. 4 15. 4 
4 14. 0 15. 6 54 58 11. 5 17. 3 12. 8 15. 82 47 60 12. 6 14. 6 
5 14. 4 14. 8 56 52 15. 6 12. 6 14. 0 ---- 52 -- 13. 3 
6 13. 4 15. 2 54 57 12. 4 14. 7 13. 6 ---- 50 -- 14 
7 14. 8 13. 0 54 51  12. 0 14. 3 13. 2 16. 0 48 56 10. 6 17. 3 
8 12. 8 11. 6 46 47 11. 4 12. 0 12. 0 15. 6 46 58 10. 9 15. 8 
9 ---- 13. 2 50 52 ---- 14. 2 11. 6 15. 2 40 55 11. 1 15. 2 
10 16. 0 13. 4 52 51 15. 6 15. 5 13. 2 16. 0 45 58 11. 7 15. 8 
MEAN 14. 3 14. 0 53. 4 52. 8 13. 5 14. 5 13. 4 15. 6 49 57 . 1  11. 8 15. 5 
1
4 mg/kg/day x 3 in 0. 3 cc di luent 3 t imes every 24 hours. 
2
Animal died soon after inj ect ion of sal inomyc in. Data not col lected. 
t\) 
(t) 
TABLE 4 (Continued) 
JUST PRIOR TO FIRST INJECTION 24 HRS. AFl'ER LAST INJECTION 
Mean Corpuscular Mean Corpuscular 
Volune ( fl )  Herroglobin (pg� 
Mean Corpuscular Mean Corpuscular Mean Corpuscular Mean Corpuscular 
Haooglobin Con- Volune (fl) 
centration(g/dl) 
HaJDglobin (pg) Heooglobin Con-
centration(g/dl_) 
Diluent Salina- Diluent Salina- Diluent Salina- Diluent Salina- Diluent Salina- Diluent Salina-
Mouse Control mycin Control mycin Control mycin Control mycin Control mycin Control mycin 
No. Group Group Group Group Group Group 
1 36 10 27 53 
1 
15 29 -- -- -- -- --
2 43 34 11 10 26 25 45 39 12 1 1  26 27 
3 34 39 9 1 1  27 28 47 36 12 10 25 26 
4 47 34 12 9 26 27 37 41 10 11 27 26 
5 36 41 9 12 26 29 39 
1 
11 27 -- --
6 44 39 1 1  10 25 27 36 
1 10 27 -- --
7 45 36 12 9 27 26 45 32 12 9 28 29 
8 40 39 1 1  10 28 25 42 37 1 1  10 26 27 
9 -- 37 -- 9 -- 25 36 36 11 10 29 28 
10 33 33 10 9 31 26 39 37 11 10 29 28 
MEAN 40 37 11 10 27 27 42 37 12 10 27 27 
·1 
Ani mals died soon after injection of salinomycin. Data not collected. 
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Figure 7 
Effects of I. P. administered salinomyc in 
on Wintrobe Erythrocytic Indexes of Mice 
□ Diluent Control Group (Ethanol-PBS-Propylene­Glycol Diluent, admini­stered 3 times every 
24 days. 
Salinomyc in Group 
(4 mg/kg/day ) ad­
ministered every 
24 hours )  
4 5  
40 
35 
30 
25 
20 
15 , 
10 
5 
0 
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Volume (fl) 
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injection injection 
Figure 7 
Mean 
Corpuscular 
Hemaglobin (pg) 
Just prior 
to first 
injection 
24 hours 
after last 
injection 
Mean Corpuscular 
Hemaglobin Concen­
tration (g/dl) 
Just prior 24 hours 
to first after last 
injection injection 
(;J 
ts, 
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Table 5,  untreated mice all died between days 6 and 12 post-
infection while the group of treated mice lived almost twice 
as long and died between the twelth and nineteenth day post­
infection. This increase in MST was determined to be 
statistically significant by student ' s  T-Test . 
Wide-Range Dose Response of P. berghei Infected Mice to 
Salinomycin 
Because the salinomycin suspension appeared to be ef­
fective in prolonging the MST of infected mice , an attempt 
was made to define the lower limits of dose effectiveness 
in Plasmodium infected mice. Two experiments were performed 
in order to determine the most efficacious dose for multiple 
administration of salinomycin in mice. 
In the first experiment, six groups of eight to ten 
male ICR mice, with an average weight of 28 grams, were in­
jected I.P. with 0. 3 ml of a sodium citrate solution containing 
5 x 106 infected erythrocytes. Subsequently, five of these 
mouse groups were injected I. P. with either 0. 3 cc of diluent 
solution, or 2, 4, 6 or 8 mg/kg/day of salinomycin suspen­
sions five times, every 24 hours. One group of eight mice 
received no further treatment after infection. Animals were 
observed daily for signs of disease or death. Periodic post 
mortems were performed and Geimsa stains of mouse bl ood were 
made to insure deaths were due to malaria. Efficacy of the 
drug was determined by comparison of the MST of each treated 
group with that of the infected untreated group. As shown 
in Table 6 and Figure 8, there was a slight, significant 
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Table 5 
EFFIC AC Y OF I. P. ADMIN ISTERED S ALINOM YCIN SUSPENSION
1 
ON 
THE MST OF P. BERGHE I INFECTED2MICE 
Day Post I nfection 
0 
1 4 
24 
3 
4 
54 
6 
7 
8 
9 
10  
11  
12 
1 3  
14 
15  
16  
17  
18  
1 9  
20 
Total No . Mice 
MST 
Number of Mouse Deaths by Day 
Untreated 
0 
0 
0 
0 
0 
0 
2 
1 
3 
3 
0 
0 
1 
10  
8.2 
Salinomycin 
0 3 4 3 
4 
0 
0 3 
1 
0 
0 
0 
0 
0 
0 
1 
0 
1 
2 
3 
0 
3 
1 
20 
16.0 
1 8 mg/ kg/ day , admi nistered 24, 48 and 96 hours post infection. 
2 5 x 106 infected ery throcy tes/ mouse in 0.3 cc sodium citrate 
sol ution . 
3Deaths probably due to drug tox icity . Not used in MST de­
termi nation. 
4 Drug admi nistered th is day. 
35 
Table 6 
WIDE-RANGE DOSE RESPONSE OF P. BERGHE I J INFECTED M I CE 
TO I .P. ADM I _  I STERED SAL INOMYCIN 
Number of Mouse Deaths by Day 
Day Post Infected, Infected, 
Infection Untreated Diluent 
0 0 0 
1 4 0 0 
2 4 0 0 
3 4 0 0 
4 4 0 0 
5
4 
0 1 
6 1 5 
7 0 1 
8 4 2 
9 0 0 
10 0 0 
11 0 0 
12 1 0 
13 2 1 
14 0 0 
15 0 0 
16 0 0 
17 0 0 
18 0 0 
19 0 0 
20 0 0 
Total No. 
Mice 8 10 
MST 9. 5 7.1 
Infected Infected Infected Infected 
2 mg/kg Day 4 mg/kg/Day 6 mg/kg/Day 8 mg/kg/Day 
Salinanycin Salinanycin Salinanycin Salinanycin 
0 0 2 3 2 3 
0 0 1 3 1 3 
0 0 1 3 0 
0 0 0 1 3 
0 0 0 0 
0 0 0 0 
0 0 0 0 
2 0 0 0 
1 0 4 0 
1 0 0 0 
0 0 0 0 
2 2 0 0 
1 3 0 1 
2 2 0 2 
1 2 0 1 
0 0 0 0 
0 0 0 0 
0 0 0 0 
0 1 1 0 
0 0 0 0 
0 0 1 0 
10 10 10 10 
10.5 13.0 11. 7 13.8 
1
5 X 10
6 infected erythrocytes/mouse, inj ected I .P. in 0. 3 cc 
sodium citrate solution. 
2 2-8 mg/kg/day, administered I.P. X 5, every 24 hours after 
infection. 
3Deaths probably due to drug toxicity. Not used in MST de-
termination. 
4Drug administered this day. 
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increase in the MST of sal inomycin t reat ed an imals which 
recei ved 8 mg/kg/day of drug. 
In a rel ated experiment , tive groups of 8 to 10 mice 
were similarly in fect ed, but with 9 x 1 0
5 
infect ed erythro­
cyt es. Thi s  t i me,  three groups o.:f animals received 2 ,  4, 
or 6 mg/kg/day of sal inomycin suspended in 0.3 cc of dilu-
ent .  Again , one groups was inj e�t ed only  with diluent and 
on e group of ei ght ani mal s received no further t reat ment 
aft er in fect i on .  Sal inomycin or diluent inject i on s  were 
administ ered fi ve t imes, at 48 hour int erval s aft er infec-
t i on,  in order t o  det ermine possi bl e effect s on MST in mice 
receiving a somewhat l ower inoculum of Pl asmodium, as wel l 
as an increase in the  t i me int erval bet ween drug administ ra­
t i ons. As shown in Tabl e 7 and Figure 8 ,  there was a st eady 
increase in the  MST of infect ed ani mal s  t reat ed with salinomycin.  
Doses of 4 an d 6 mg/kg/day caused si gn i ficant increases in 
the MST of Pl asmodium infect ed mice. As in the previous 
experi ment s, all an i mal s eventual l y  di ed of mal aria. 
Effi cacy of Sal inomycin on Low Init i al Inoculum In fect ion s  
of P .  bergh ei i n  Mice 
With the est abl i shment of rel ati vel y effect i ve dose 
ran ges in the previ ous experi ment s, studi es were desi gned t o  
t est the effect iven ess of the drug when the number of 
parasit es was severel y l i mit ed. The effect s of I.P. ad­
min inst ered sal inomycin on infect ion s  result in g from ult ra­
l ow init ial inocula were studi ed in the n ext t wo experiments. 
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TABLE 7 
J 
WIDE-RANGE DO8E RESPONSE OF P. BERGHEI INFECTED MICE 
TO SALINOMYCIN2 
Number of Mouse Deaths by Ihy 
Infected Infected Infected 
Day Post Infected, Infected, 2 ng/kg 4 ng/kg 6 �/kg 
Infection Untreated Diluent Salinanycin Salinanycin Salinanycin 
0 0 0 0 0 0 
1 0 0 0 1 3 2 3 
2 4 0 0 0 0 0 
3 1 0 0 0 0 
4 4 2 0 0 0 0 
5 1 0 0 0 0 
6 1 0 0 0 0 
7 2 5 0 0 0 
84 1 2 0 1
3 
3
3 
9 0 2 9 1 0 
10
4 
0 0 1 3
3 
0 ------------------------------------------------------------
14 0 1 0 0 0 
18 0 0 0 2 2 
19 0 0 0 2 0 
20 0 0 0 0 2 
21 0 0 0 0 0 
22 0 0 0 0 1 
Total No. 
Mice 8 10 10 10 10 
MST 5.1 8.3 9.1 18 . 5  19. 6 
1 9 X 105 infected erythrocytes/mouse , inj ected I . P. in 0 . 3  cc 
sod ium citrate sol ution . 
22-6 mg/kg/day administered I. P. 5 times every 48 hours after 
infection. 
3 Deaths probably due to drug toxicity. Not used in MST de-
termination. 
4 Drug administered this day. 
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Figure 8 
Wide-range dose response of � - berghei 
infected mice to I.P. administered 
Salinomycin. 
Infected, untreated control 
§ Infected, diluent control 
� 
Infected, 2 mg/kg/day salinomycin 
II Infected, 4 mg/kg/day salinomycin 
Ill]] Infected, 6 mg/kg/day salinomycin 
Infected, 8 mg/kg/day salinomycin 
Five I. P. injections, once 
every twenty-four hours 
after infection with 
5 x 10
6 
infected erythro­
cytes 
F igure 8 
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Five I.P. injections, once 
every forty-eight hours 
after infection with 
9 x 10
5 
infected erythro­
cytes 
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In the first experiment, two groups ot ten mice, wit h 
an average weight of 33 grams, were i njected J. P. with 0. 3 
cc sodium citrate solut ion conta in ing 1 x 103 infected ery­
throcytes. One group received no further treatment. The 
other group received on t he same day 4 mg/kg/day of salino­
mycin suspension administered I.P. in 0.3 cc of diluent, 
and treatment was cont inued at 24 hour intervals for a total 
of five inject ions. As seen in Table 8, MS T act ually de­
creased slightly in an imals receiving salinomycin suspension 
when compared to infected, untreated animals. Thus, salino­
mycin had no posit ive effect on the MS T of animals infected 
wit h  very low innocula of P. berghei. 
A second experiment was performed in which mice re­
ceived an I.P. inject ion of 102 infected erythrocytes , 
as in the procedure previously described. The init ial 
inoculum was apparently too low to cause a successful in­
fect ion of the blood stream from the perit oneal cavit y ,  
since no disease occurred. 
Efficacy of Salinomycin on Est ablished Plasmod ium Parasi­
temias in Mice 
In this set of experiment s ,  det ect able parasitemias 
were allowed to develop before treatment with salinomycin 
was st arted. S ince salinomycin appeared to  have no effect 
on MS T when administered simult a neously with a low dose 
TABLE 8 
EFFICAC Y OF I.P. ADMINIS TERED SALINOM YCIN �  ON LOW IN ITIAL 
INOCULATION INFECTIONS OF P. BERGHEI 2 IN MICE 
Nunber of Mouse .Deaths 
Day 
0 4 
1 4 
2 4 
3 4 
4 4 
5 4 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
28 
Tot al No . Mice 
(S urv ivors ) 
MS T 
Infected , 
Untreated Group 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
1 
2 
0 
0 
1 
0 
2 
1 
1 
8 (  2 )  5 
20. 6 
Infected , 
Salinomycin Treated 
0 
1 3 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
2 
0 
1 
1 
0 
0 
0 
0 
1 
1 
0 
0 
7 ( 3 ) 5  
16.7 
14 mg/kg/ day adm inistered I.P. immediately after infect ion 
and every 24 hours f ive t imes thereafter. 
2 1 x 10
3 
i nfected erythrocytes ,  i nj ected I.P. in 0.3 cc 
sod i um citrate sol ut ion. 
3 Death probabl y  due to drug tox icity. Not used in MS T de­
termination .  
4
Drug administered this day . 
5
( No.) = Animals surv iving infect ion. 
4 1  
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inoculum of Plasmodium, the other extre�e was examined. In 
t h is set of experiments, detectable ·parasi'temias were 
allowed t o  develop before treatment with salinomycin was 
st art ed. The number of parasites present in each animal at 
the st art of t reatment thus was far greater than in the 
prev ious experiments. One experiment started with a rela­
t ively h igh est ablished parasitemia, the other with a low 
parasitemia. 
The f irst experiment ut ilized three groups of ten mice 
each , with an average weight of 32 grams. The mice were 
inoc ulated I. P. with 5 x 10
6 
infected erythrocytes in 0. 3 
cc sodium c itrate solution. 
The infect ions were allowed to become est ablished and 
developed unt il the mice in all three groups had an average 
parasit emia of 45 % ,  six days after inoculat ion. One group of 
animals was given f ive I . P. inject ions of 4 mg/kg/day of 
salinomyc in in et hanol-PBS -propylene glycol suspension. 
Anot her group was similarly injected but wit h diluent only , 
a th ird group received no furt her treatment after infect ion . 
As can be seen in Table 9 ,  there was no signif icant increase 
in the MS T of salinomyc in treated animals , when compared to 
the MS T of t he unt reated and diluent cont rol animals. In 
fact , most salinomyc in treated animals died earlier than the 
cont rol mice. 
In the second experiment , drug administrat ion began 
three days after infect ion with Plasmodium , when the average 
TABLE 9 
EFFICACY OF I . P .  ADMINI STERED SALINOMYC IN
1 
ON 
ESTABLISHED PLASMODIUM PARAS ITEMIAS 2 IN MICE 
Number of Mouse Deaths bi Dai 
4 3  
Day Post- Infected, Infected , Infected , 
infection Untreated Diluent Salinomycin 
0 
1 
2 
3 
4 
5 3 
6
3 
7
3 
8
3 
9
3 
10 
12 
18 
19 
0 
0 
0 
0 
0 
0 
0 
2 
3 
3 
1 
0 
1 
0 
Group 
0 
0 
0 
0 
0 
0 
0 
3 
4 
2 
1 
0 
0 
0 
( 4 mg/kg/day Group ) 
0 
0 
0 
0 
0 
6 1+ 
0 
0 
1 
1 
0 
1 
0 
1 
Total No. Mice 10 10 10 
MST 9 . 3  8.1 9.1 
4 mg/kg/day, administered on day five and every 24 hours 
2 after -
Average parasitemia of 45% of day six. Initial inoculum 
5 x 106 infected erythrocytes. 
3
Salinomycin administered this day. 
deaths this day probably due to drug toxicity, not used in 
dST determination. 
4 4  
parasitemia was 7%. The initial inoculum was 5 x 104 in­
fected erythrocytes /mouse in Q. 3 cc  sodium citrate solution. 
One group of ten mice received no further treatment after 
infection, the other group of ten received five I . P. in­
jection s of 4 mg/kg/day salinomycin suspension . As shown in 
Table 10, there was no significant increase in the MST of 
salinomycin treated animals , when compared to infected 
untreated controls. 
Efficacy of Orally Administered Salinomycin on I nfections 
of P. berghei in Mice 
I n  this experiment , the effects of multiple oral ad­
ministrations of salinomycin in Plasmodium infections in 
mice, as well as the possible effects on normal murine 
intestinal flora. Five groups of eight to ten mice with 
an average weight of 39 grams were maintained. Three of 
these groups were injected I . P. with a 5 x 106 infected 
erythrocytes in 0. 2 cc sodium citrate diluent. One of 
these groups received 30 mg/ kg/day salinomycin in 0. 2 cc 
diluent administered orally with an 18-gauge gavaging needle 
five times, once every 24 hours after infection. Another group 
was similarly administered the diluent only. A third group 
of mice received salinomycin without being infected, in 
order to determine the effects of orally administered 
salinomycin on normal, healthy mice. A fourth group was 
infected, but received no further treatment. The final 
group of mice was kept uninfected and untreated , to serve 
TABLE 10 
EFFICACY OF SALINOMYCIN
1 
ON ESTABLISHED PARASlTEMIAS 2 
IN MICE 
Number of Mous e Deaths by Day 
Day Inf ected, Infected, 
Untreated Salin omycin 
Group Group 
0 0 0 
1 0 0 
4 
1
3 
1
3 
2 
4 
3 0 0 
4 0 0 
5
4 
0 0 
6
4 
1 0 
7 0 0 
8 0 0 
9 1 0 
1 0  1 0 
1 1  0 0 
1 2  1 0 
1 3  0 2 
1 4 3 0 
1 5  0 1 
1 6  0 3 
1 7  1 2 
2 3  0 1 
Total No. Mice 9 10 
MST 10 . 6 9 . _8 
� 4  mg/kg/day. 
Average Paras itemia of 7% of day two. 
3 Mo use death probably not due to Plasmodium infection . Not 
used in  MST determination . 
4 Drug administered this day. 
4 5  
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as a control for the comparison of i ntestinal flora with  
tota l treated animals. 
As i nfected mice became moribund or died, post mor­
tems were performed. Spleens and livers exhibited darken­
i ng and enlargement , indicating infection by Plasmodiurn .  
As shown in Table 11 , there was no significant devi­
ation in MST of salinomycin treated animals compared to 
untreated mouse groups. Uninfected mice receivi ng ora lly 
administered sali nomycin exhibited no qualitative differ­
ences i n  i ntestinal  f lora when compared to swabs taken from 
uni nfected , untreated animals (data not shown ) .  Moribund 
anima ls i nfected with malaria demonstrated a marked absence 
of l i v i ng Trichomonas, pi nworms and even bacter ia , when 
compared to i ntest i nal  specimens from hea lt hy , unt reat ed 
m i c e .  
4 7  
T ABLE 11 
EFFECTS OF ORALL Y ADMINISTERED S ALINOM YCIN1QF INFECTIONS 
OF P. BERGHEI2 IN MICE 
Day 
0 
Number of Mouse Deaths by Day 
Infected , Infected , Infected , 
Untreated Mice Diluent Control Salinomyci n 
2* 0 3 *  ------------------------------------------------------------
6 0 0 0 
7 0 2 0 
8 1 2 0 
9 0 1 0 
10 0 0 0 
1 1  0 0 2 
12 0 0 3 
13 0 0 0 
14 2 2 0 
J,.5 0 0 0 
16 0 0 1 
17 2 1 0 
18 1 0 0 
28 0 0 1 
Tota l No. Mice 8 8 10 
MST 13 . 5  11 . 8 14 . 6 
* Mouse probab ly deaths not due to P lasmod ium . Not used 
i n  MST determination. 
30 mg/ kg/ day in 0. 2 cc diluent . 
2 
5 x 106 i nfecte d erythrocytes i n  0 . 2  cc sod ium c i t rate  
solut ion . 
DISCUSSION 
The screening of subst ances for use as possible anti­
malarial agent s  has traditionally been a massive, low-yield 
undertaking. During World War II, more than 15, 000 chemical 
substances were screened by t he United St ates Government in 
order to  find new effective antimalarial agents (Peters and 
Howells , 1970).  The low success rate is typified by a more 
recent U.S. Army screening. Primary testing of 300 compounds 
was begun in experiments utilizing murine malaria similar to 
those described previously. Only 54 compounds of 300 were 
found to  have any antimalarial activity. In similar screens 
with multiple drug resistant strains, fifteen more potential 
drugs were elimiated. Of the remaining 39 compounds , only 
one survived similar malaria screens, and this compound had 
yet to be tested for human toxicity (Kennamon et al . ,  1975 ) .  
Research with murine Plasmodium species, particularly 
P. berghei increased dramatically in the 1960' s, along with 
the involvement of the U.S . Armed Forces in Southeast Asia 
(Pet ers and Howells, 1978) . Most of this research was o f  
a pharmacological nature, the testing of the efficacy o f  
various substances on the chloroquine resistant strains 
of Plasmodium encountered by U . S . troops in this part o f  the 
wor l d .  The use of murine specific malaria has served to 
great ly facilitate the screening of large numbers of po­
tential ant imalarial compounds . Before the advent o f  wide-
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spread use of murine Pla�modia for research in ant imalarial 
chemotherapy , most work was done using avian and simian 
models. These systems proved to be both expensive and 
difficult to manipulate (Peters , 1970) .  
The NYU-2 strain of Plasmodium berghei has been shown 
to be particularly lethal in the experiments described here . 
In no instance did any mice infected with � - berghei and 
subsequently treated with salinomycin survive for more than 
28 days after infection. 
The appearance of Plasmodium strains natura l ly res i s­
tant to many popular antimalarial drugs has prompted re­
searchers to examine new compounds for use as poss i b le 
chemotherapeutic agents . Salinomycin was cons i dered in 
this study because it has been shown effective in con­
troll i ng intestinal infections by another sporozoan , 
Coccidia. Also, there are no known res i stant stra ins of  
organisms sensitive to salinomycin or i ts related iono-
2 
phores . 
In a preliminary study , mice were inoculated w i th 
Plasmodium in order to follow the effects on certa in hema­
tolog ic  values during the course of infection . Th i s  was 
done in order to provide some baseline informat ion on the 
potency of P. berghei in this system. The data also i l l u­
strates the effects of this portion of the life cyc le on 
2
statement by Dr. R.G. Stroud, Professor of An ima l 
Sc i e nce at the University of New Hampsh ire in an add ress 
( " Coccidiasis and Ionaphoric Coccidi astats " )  at  the A . H .  
Rob ins Seminar Series of May 22, 1980 . 
50 
the ver tebrate hos t . The declin e in hemat ocrit leve l s  
( F i gure 6, Tab l e  2 )  was invers ly proportional t o  the r i se 
i n  pa ras i temia coun t s  wit h t ime and probably due t o  t h e  
des t ruct ion o f  i n fected eryt h rocytes dur i n g  schizogeny. 
The decreased b l ood hemaglob i n  level s were due t o  t he 
breakdown o f  hemagl ob i n  t o  hemazoin s an d o t he r  product s by 
the  i ncreas i ng number o f  in t raeryt hrocytic parasites. 
Sal i nomyc i n  has proven to be a d i f ficul t drug t o  use 
in the  expe r i men tal mode l described. The drug i s  h igh l y  
tox i c  to  m ice , hav i ng LD
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va l ues o f  1 0 . 8  mg/ kg/ day i f  
adm i n i s tered I . P .  and 80 �g/ kg/ day when given orally ( Kaken 
dat a shee t ) .  I n  con t ras t, conce n t rations  o f  potential  
an tima l a r i al age n t s  used in other  inves t igat i o n s  have 
exce l l ed 60 mg/ kg/ day, g i ven subcutaneous l y  ( Adviado et  
� - , 1969 ) . Qui n i ne has  been adm i n i s tered oral ly  t o  m ice 
as a re ference durg i n  concen t rat i o n s  exceed i ng 100  mg/ k g / day 
( Thomps on , 1972 ) .  C l early , it may not  be poss i ble to admin i­
s t e r  sal i nomycin in h igh enough conce n t rat i o n s  t o  el iminate 
t he paras i te f rom the b l ood s t ream. The l e thal dose range 
( Ta b l e  1 )  was per formed t o  obtain some es timate o f  t he 
number o f  mouse deat h s  t hat could be expected at t he re­
lat ive ly high conce n t ration s used . An at tempt was made t o  
s t r i ke a de l icate bal ance between conce n t rat i o n s  o f  sal i no­
myci n h igh enough t o  have a pos i t i ve e f fect on the  course 
of i n fect ion  and l ow enough to preve n t  the deaths  of an 
i nord i n a n t  n umbe r  o f  an imals  due t o  drug t oxic i t y. Th e 
s i x  mous e deat hs on day f i ve ( Tab l e  9 )  i n  t he i n fe c t ed 
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sal inomycin treated group may be due to a lowered toleran ce 
of  the drug with a concurrent Plasmodium infection. Heavy 
adult mice were used in all experiments because they were 
more resistant to adverse effects of the drug than younger 
mice ( data not shown) . 
A second problem with the use of salinomycin in vivo 
was the difficulty in finding a non-toxic solvent in which 
to d issolve the drug. Salinomycin is highly soluble in 
such solvents as methanol, ethanol and benzene, but these 
substances are poorly tolerated by laboratory animals. 
Sal inomycin was in itially dissolved in absolute ethanol 
and a Propylene-glycol-PBS suspension . Care had to be 
taken to ensure the drug was adequately dispersed when 
admin istered to animals. 
Si nce malaria is a system ic disease of the blood, 
experiments were performed to determine what effects, if 
any, salinomycin might have on certain hematologic para­
meters. In the f irst experiment, the effects of multiple 
I .P .  administration of salinomycin on hemoglob in and 
hematocrit levels were examined. No sign ificant changes 
were detected 24 hours or f ive days after the last injec­
t ion (Table 3) . The experiment was repeated, this t ime 
w ith blood collected for total erythrocyte counts, so that 
the W inthrope Erythrocytic I ndexes could be calculated 
for each mouse, be fore and after treatment. These indexes 
are use ful in the det ection and defin ing of specific anemias. 
Aga in , sal inomycin appeared to have no effect on erythrocyte 
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number or size of hemoglobin concentration , 
Sa linomycin appears to be most effective against � ­
berghei when administered I.P. in relatively high concen­
trations over timed intervals greater than 24 hours. The 
MST of salinomycin suspension treated animals in the first 
experiment was almost double that of the infected untreated 
cont rols (Table 5) .  No mice wer injected with diluent.  
The experiment was designed to see if the salinomycin sus­
pension could produce any positive results with the concen-
tration of the drug used. Injections were given at varied 
intervals so as to minimize any mouse deaths due to accumu­
lated drug toxicity. 
This initial experiment was followed up by two multi­
dose studies in an attempt to define the most effective 
multi-administration regimen. This time, diluent controls 
were used. In the first experiment , animals were inoculated 
with 5 x 10
6 
infected erythrocytes while in the second ex­
periment, animals received only 8 x 10 5 infected erythro­
cytes. Mice were injected every 24 hours for five days 
with salinomycin or diluent in the former experiment, and 
every 48 hours for ten days in the lat ter. Again, MST was 
significantly higher in animals injected every 48 hours 
with 4 mb/kg/day or more of salinomycin when compared to 
infected untreated controls (Tables 6-7 ) . Results indi­
cate that for similar doses of salinomycin, the length of 
the treatment period may be more important than the fre­
quency of treatment. 
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The extraordinarily low MST in the infected, untreated 
control second multidose experiment is worthy of note . 
This MST is almost half that of the infected control of 
the first experiment, yet animals in this group were given 
a substantially lower inoculum of infected erythrocytes. 
When the MST of treated animals in the second experiment 
are compared with those of the control animals of the 
second, there is no significant lengthening of MST. This 
low MST in the first control group would be due to the 
presence of a larger number of infected erythrocytes in 
the inoculum than was actually calculated. 
Treatment with salinomycin produced no significant 
increases in MST when given to animals with established 
parasitemias or those infected with low numbers of parasi-
tized erythrocytes (Tables 8-10) .  In the latter experiments, 
treatment with salinomycin began immediately after infection, 
instead of delaying at least 24 hours. Such ne�ative re­
sults contrast with the results seen earlier, where animals 
receiving higher inoculum had higher MST upon treatment with 
salinomycin. 
The oral administration experiment yielded no positive 
results (Table II) . This was to be expected because of  the 
insoluble nature of salinomycin, even in suspension. It 
was i mprobable that any significant amounts of salinomycin 
was absorbed by the intestinal tract and entered the blood 
streatm . No gross changes in normal intestinal flora were 
noted . Subtle changes in the microbial populations could 
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have occurred with salinomycin treatment, but these would 
have gone unnoticed since no quantitative assays were per­
formed. 
As previously mentioned, salinomycin has a demonstrated 
ability to shut down both coupled and uncoupled respiration 
in mitochondria. Other monocarboxylic polyether antibiotics 
have exhibited similar physiological effects on other cellu­
lar organelles and on such are considered valuable tools for 
the study of ion-carrier mechanisms in vivo (Mitani et al. , 
1976) . 
In murine-specific Plasmodium, the existance of two 
electron transports systems within the parasites mitochon­
cria i s  strongly suspected, but unconfirmed. Antimycin A 
and rotenone, two electron transport inhibitors, have both 
proven effective in the inhibition of chloroquine induced 
hemazoin pigment clumping, an energy dependent process 
which occurs in the absence of oxygen (Homewood et al., 
1 972) . The presence of � - berghei specific co-enzyme Q 
has also been demonstrated (Skelton et al., 1970) . Intra­
erythrocytic malaria parasites are separated by three cellu­
l ar membranes from the external circulating blood fluid. The 
problem with salinomycin may be in getting the drug into 
the site of respiration in quantities sufficient to shut 
down the process. Coccidial sporozoites, for example, are 
not destroyed by cationic ionophores unless they penetrate 
the external membranes of the host cells (McDougald and 
Ga l l oway , 1976) . Schizonts leaving the ruptured erythro-
5 5  
cytes are devoid of these protective erythrocytic mem­
branes still appe ar to be quite capable of continuin the 
disease cycle in animals treated with salinomycin. 
As with the electron transport systems, little is 
known about the other Plasmodium membrane transport sys­
tems, expecially the ion transport systems of mitochon­
dria. 
Salinomycin has a limited effect on the course of 
malaria in mice. Best results were obtained when s alino­
mycin was administered I.P. in dose s  exceeding 4 mg/kg/day. 
Extending the period of drug treatment seemed to prolong 
survival time in infected animals. I.P. administration 
started at the same time as inoculation of low numbers of 
parasites had no positive effects on the MST of infected 
mice , nor did s alinomycin have any effect when given I.P. 
to mice which already had established, detectable parasi­
temias .  Likewise, oral administration had no positive 
effect on the MST of infected mice. Two serious problems 
affecting rese arch with salinomycin are the high degree 
of toxicity to mice, and the drug ' s  low solubility in 
most sol vents suitable for insertion into biologica l sys­
tems . 
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APPENDICES 
I .  ABBREVIATIONS 
HGB 
HCRIT 
I. P. 
MCHC 
MCH 
MCV 
MST 
PBS 
PCV 
Hemoglobin 
Hematocrit 
Intraperitoneal 
Mean corpuscular hemoglobin 
concentration 
Mean corpuscular hemoglobin 
Mean corpuscular volume 
Mean survival time 
Phosphate buffered saline 
Packed cell volume 
6 1  
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I I . RECE I PES 
A .  Preparation of 0.16M Phosphate Buffered Sal ine 
B .  
25X Stock Solution 
ADD :  
1 7 0  ml distilled H20 
5.48 grams Na
2HPo4 
1. 58 grams NaH2Po4 
q. s. to 200 ml with distilled H2o 
lX Worki ng Solution 
ADD : 
40 ml of 25X stock solution 
8.5 g Na Cl 
q. s. to 1000 ml with distilled H2o 
pH 7.21 � . 05 adjust with 1 N HCl or lN NaOH 
Preparation of 0.14M Sodi um C itrate Solution 
ADD :  
3 grams sodium citrate 
.83 grams dextrose 
100 ml distilled H2O 
Mill ipore filter into sterile bottle 
